108605
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
微小核糖核酸 326：有望成为癌症的生物标志物
Authors Pan YJ, Wan J, Wang CB
Received 19 July 2019
Accepted for publication 2 December 2019
Published 11 December 2019 Volume 2019:11 Pages 10411—10418
DOI https://doi.org/10.2147/CMAR.S223875
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Eileen O'Reilly
摘要：微小核糖核酸是小的非编码且高度保守的核糖核酸，其在生物学过程中发挥作用，包括细胞增殖，侵袭，凋亡，代谢，信号转导和肿瘤发生。据报道，微小核糖核酸 326 参与其中。在细胞凋亡，肿瘤生长，细胞侵袭，胚胎发育，免疫调节，化疗抵抗和肿瘤发生中具有重要作用。这篇综述详细介绍了微小核糖核酸 326 对细胞侵袭，转移，耐药性，增殖，凋亡及其在信号通路中的作用。
Keywords: MicroRNA, miR-326, tumor suppressor, cancer, metastasis, oncogene
